CEACAM6 Polyclonal Antibody

Background:
Carcinoembryonic antigen (CEA; MIM 114890) is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. An apparent lack of absolute cancer specificity for CEA probably results in part from the presence in normal and neoplastic tissues of antigens that share antigenic determinants with the 180-kD form of CEA (Barnett et al., 1988 [PubMed 3220478]). For background information on the CEA family of genes, see CEACAM1 (MIM 109770).

Research Area: Cancer, Tags and Cell Markers

Synonyms:
Carcinoembryonic antigen related cell adhesion molecule 6, Carcinoembryonic antigen related cell adhesion molecule 6 (non specific cross reacting antigen), Carcinoembryonic antigen-related cell adhesion molecule 6, CD 66c, CD66c, CD66c antigen, CEA LIKE PROTEIN, CEACAM 6, CEACAM6, CEAL, CEAM6, MGC93832, NCA, Non specific cross reacting antigen, Non-specific crossreacting antigen, Normal cross reacting antigen, Normal cross-reacting antigen

Immunogen: Synthetic peptide of human CEACAM6

Swissprot: P40199
Gene Accession: NP_002474

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.6 mg/mL
Dilution: IHC 1:50-1:200

Storage:
Store at -20°C. Avoid freeze / thaw cycles.